AstraZeneca’s Bob Li on the MARS mission to eliminate cancer
Bob Li, AstraZeneca's Global Head of Medical Affairs, Oncology, on why only 7 percent of cancer patients get access to clinical trials, and what decentralized trials, AI, and international collaboration could do to change that within a decade.
Primary source
mckinsey.com ↗
Overview
Bob Li, AstraZeneca's Global Head of Medical Affairs, Oncology, on why only 7 percent of cancer patients get access to clinical trials, and what decentralized trials, AI, and international collaboration could do to change that within a decade.
Source
Originally published at www.mckinsey.com.
Related Articles
From our network: explore the AI assistant platform behind this site.
Visit tunx.ai →
Note: This story is aggregated and summarized from the primary source linked above; the original publisher retains all rights. Details may evolve after publication — always confirm against the source. Nothing here is professional, legal or investment advice.
